Date: 2011-11-02
Type of information:
Company: Fresenius (Germany)
Investors:
Amount: €100 million
Funding type: private placement via issuance of senior notes
Planned used: The proceeds will be used to repay debt and for other undisclosed corporate purposes.
Others: Fresenius Medical Care has announced the pricing of euro denominated floating-rate senior notes. The aggregate principal amount to be issued is €100 million. The Senior Notes will be issued at par and carry interest of three-months Euribor plus 350 basispoints. The Senior Notes will mature on October 15, 2016. The Senior Notes will be offered by FMC Finance VIII S.A., a wholly-owned subsidiary of the Company, in a private placement outside the United States to non-US institutional investors only. The Senior Notes will be guaranteed jointly and severally by the Company and its subsidiaries, Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Deutschland GmbH. The Company expects to close and settle the offering on October 17, 2011, subject to customary closing conditions.
Therapeutic area:
